RPS14P7

Across TCGA pan-cancer cohorts, RPS14P7 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RPS14P7 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPS14P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS14P7 expression acts as an unfavorable survival marker.

BLCA, READ, and CHOL are the cancer types where RPS14P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	III,IV	0.311	0.659	<.001	144	view →
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	72	view →
CHOL	DFS	Tertile	II,III,IV	0.049	0.430	.014	54	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	54	view →
SKCM	OS	Tertile	All	0.365	0.790	<.001	39	view →
LIHC	DFS	Tertile	All	0.234	0.567	<.001	39	view →
ESCA	OS	Tertile	All	0.348	0.944	.007	33	view →
STAD	DFS	Tertile	IV	0.292	0.579	.021	27	view →
THCA	DFS	Tertile	II,III,IV	0.136	0.764	.008	21	view →
LUAD	DFS	Tertile	III,IV	0.309	0.686	.009	21	view →
COAD	OS	Tertile	II,III,IV	0.389	0.795	.011	18	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RPS14P7–BLCA (OS)

Open the BLCA breakdown →